HIGHLIGHTS
- who: Dietmar Krex and collaborators from the Department of Neurosurgery, University Hospital, Technical University Dresden, Dresden, Germany have published the research work: Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas, in the Journal: (JOURNAL)
- what: The authors investigate whether the combination of TTFields with the chemical Aurora B kinase inhibitor AZD1152 enhances the anti-tumor effect on glioblastoma cells by additionally inhibiting cytokinesis.
- how: Sequencing data were compared with sequence of wild-type p53 using ApE-A Plasmid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.